Mediclinic International (MDC.L) 20-04-20
Will Mediclinic International (MDC.L) shares break below the 250p support, or return to highs of 415p (+65%)?
- Currently close to the 250p support at 251.2p (at time of writing).
- This has been identified for ostensibly strong support level. Traders should consider whether they think it will hold up again.
- Will the price bounce again to recent highs at 415p? (+65%).
- Technical traders should consider potential news and developments. Check our website and the press for updates in future.
- Shares -39% from 12-month highs; +2% from 12 month lows.
Latest News
17 Apr: Mediclinic International, the healthcare company, announced it had paused dividends and had reached an agreement on debt covenant waivers, due to concerns over the Covid-19 pandemic.
14 Apr: HSBC reiterates its reduce rating on Mediclinic International Plc (MDC) and reduced the target price to 270p (from 310p).
27 Mar: Mediclinic announced that it had appointed Inga Beale as chairman. She is due to replace Edwin Hertzog following his retirement.
07 Feb: Mediclinic announced it had obtained competition clearance on its proposed acquisition of South Africa’s Matlosana Medical Health Services.
21 Jan: Jefferies International reiterates its buy rating on Mediclinic International Plc (MDC) and increased the target price to 482p (from 457p).
18 Dec: Barclays Capital reiterates its equal weight rating on Mediclinic International Plc (MDC) and increased the target price to 400p (from 360p).
Source: Bloomberg, Reuters, Alpha Terminal, FT, DJ Newswires